Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 13/20 | 0.69 |
| ▸ | AKR1B10 | O60218 | 2/20 | 0.69 |
| ▸ | AKR1A1 | P14550 | 2/20 | 0.69 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1201112 | 1.00 | AKR1B1 (0.69) | AKR1B1AKR1B10AKR1A1MAPT | |
| SCHEMBL5925115 | 1.00 | AKR1B1 (0.69) | AKR1B1AKR1B10AKR1A1MAPT | |
| SCHEMBL10577770 | 1.00 | AKR1B1 (0.69) | AKR1B1AKR1B10AKR1A1MAPT | |
| SCHEMBL10575326 | 1.00 | AKR1B1 (0.69) | AKR1B1AKR1B10AKR1A1MAPT | |
| SCHEMBL29392626 | 1.00 | AKR1B1 (0.69) | AKR1B1AKR1B10AKR1A1MAPT | |
| SCHEMBL10607407 | 0.86 | AKR1B1 (0.74) | AKR1B1AKR1B10AKR1A1MAPT | |
| SCHEMBL10575841 | 0.86 | AKR1B1 (0.54) | AKR1B1AKR1B10AKR1A1 | |
| SCHEMBL10373488 | 0.85 | AKR1B1 (0.63) | AKR1B1AKR1B10AKR1A1 | |
| SCHEMBL25892734 | 0.85 | AKR1B1 (0.63) | AKR1B1AKR1B10AKR1A1 | |
| SCHEMBL10574757 | 0.84 | AKR1B1 (0.65) | AKR1B1AKR1B10AKR1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 309 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4279580-B1 | METHOD FOR SEPARATING AND CULTURING GINSENG STEM CELLS | SHANGHAI KODILIN TECH CO LTD (CN) | 2026-03-11 | — | — | EP | claimed |
| EP-4278892-B1 | CULTURE METHOD FOR ADVENTITIOUS ROOTS OF PANAX GINSENG C. A. MEY. BY USING A BIOLOGICAL DEVICE | SHANGHAI KODILIN TECH CO LTD (CN) | 2026-03-11 | — | — | EP | claimed |
| CN-115389639-B | Method for targeted identification of crocin compound and novel crocin compound | 赣江中药创新中心 | 2025-04-29 | — | — | CN | claimed |
| WO-2025078426-A1 | METHOD AND DEVICES FOR CULTIVATING PLANTS | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2025-04-17 | — | — | WO | claimed |
| EP-4537653-A1 | METHODS AND DEVICES FOR CULTIVATING PLANTS | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2025-04-16 | — | — | EP | claimed |
| CN-118825551-A | Separator, battery cell, battery and electricity utilization device | 宁德时代新能源科技股份有限公司 | 2024-10-22 | — | — | CN | claimed |
| CN-118497242-A | Novel coronavirus nucleic acid detection quality control product based on MS2 phage virus-like particles, and preparation method and application thereof | 新疆生产建设兵团医院 | 2024-08-16 | — | — | CN | claimed |
| WO-2024053761-A1 | COMPOSITION FOR PROMOTING MYOBLAST PROLIFERATION AND DIFFERENTIATION CONTAINING ALDOSE REDUCTASE INHIBITOR | 애니머스큐어 주식회사 | 2024-03-14 | — | — | WO | claimed |
| CN-115389639-A | Crocin compound targeted identification method and novel crocin compound | 赣江中药创新中心 | 2022-11-25 | — | — | CN | claimed |
| CN-115073000-A | Low-cost silver gray ceramic pigment and production method thereof | 颜文静 | 2022-09-20 | — | — | CN | claimed |
| WO-2010065024-A1 | TOPICAL TREATMENT OF CATARACTS IN DOGS | KADOR PETER F (US) | 2010-06-10 | — | — | WO | claimed |
| US-20090082415-A1 | Topical treatment of cataracts in dogs | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 2009-03-26 | — | — | US | claimed |
| CN-122095690-A | Channel state information reporting in low power wake-up radio wireless communications | — | 2026-05-26 | — | — | CN | disclosed |
| EP-3738240-B1 | DATA RETRANSMISSION MECHANISM IN TERRESTRIAL OR NON-TERRESTRIAL NETWORKS EXHIBITING A HIGH PROPAGATION DELAY | FRAUNHOFER GES FORSCHUNG (DE) | 2026-05-20 | — | — | EP | disclosed |
| US-20260102514-A1 | CHOLINERGIC GENE THERAPY TO PRESERVE HEARING | UNIV JOHNS HOPKINS (US) | 2026-04-16 | — | — | US | disclosed |
| US-12595305-B2 | TREM2 stabilizing antibodies | NOVARTIS AG (CH) | 2026-04-07 | — | — | US | disclosed |
| EP-0172719-B1 | PROCESS FOR THE PRODUCTION AS ASYMMETRIC HYDANTOINS | PFIZER INC. (US) | 1988-09-21 | — | — | EP | disclosed |
| US-4716113-A | Process for the production of an (S)-methyl or (S)-ethyl 4-amino-6-fluorochroman-4-carboxylate | PFIZER INC. (US) | 1987-12-29 | — | — | US | disclosed |
| EP-0175312-A2 | Process for preparing optically active hydantoins | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1986-03-26 | — | — | EP | disclosed |
| EP-0172719-A1 | Process for the production as asymmetric hydantoins | PFIZER INC. (US) | 1986-02-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090082415-A1 | Topical treatment of cataracts in dogs | AKR1A1, AKR1B1, AKR1C1 | AKR1B1 2/4885AKR1B10 9/4885AKR1A1 1/4885 |
| US-20260102514-A1 | CHOLINERGIC GENE THERAPY TO PRESERVE HEARING | CHRNA9, CHAT, CHRNB4 | AKR1B1 4269/4885AKR1B10 4388/4885AKR1A1 4462/4885 |
| US-12595305-B2 | TREM2 stabilizing antibodies | FCGR2A, FCGR3B, FCGR1A | AKR1B1 3383/4885AKR1B10 4013/4885AKR1A1 3116/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.